GC
NVO

Gratry & Company’s Novo Nordisk NVO Stock Holding History

Gratry & Company’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-166,790
Closed -$4.49M – 87
2016
Q2 		$4.49M Sell
166,790
-9,018
-5% -$247K 3.53% 7
2016
Q1 		$4.76M Sell
175,808
-58,078
-25% -$1.56M 3.41% 7
2015
Q4 		$6.79M Sell
233,886
-8,424
-3% -$233K 4.42% 3
2015
Q3 		$6.57M Sell
242,310
-2,498
-1% -$70.7K 4.03% 3
2015
Q2 		$6.7M Buy
244,808
+10,122
+4% +$285K 3.51% 8
2015
Q1 		$6.26M Buy
234,686
+145,368
+163% +$3.35M 3.38% 8
2014
Q4 		$8.25M Sell
89,318
-217,420
-71% -$4.86M 2.7% 14
2014
Q3 		$7.3M Sell
306,738
-74,530
-20% -$1.72M 3.82% 3
2014
Q2 		$8.8M Sell
381,268
-51,810
-12% -$1.14M 3.47% 3
2014
Q1 		$9.88M Sell
433,078
-13,512
-3% -$288K 3.56% 3
2013
Q4 		$8.25M Sell
446,590
-2,120
-0.5% -$36.9K 2.7% 14
2013
Q3 		$7.59M Sell
448,710
-9,970
-2% -$168K 2.68% 14
2013
Q2 		$7.11M Buy
+458,680
New +$7.63M 2.76% 13

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Gratry & Company's NVO Position: Q3 2016 in Review

Gratry & Company sold out of Novo Nordisk (NVO) in Q3 2016, closing a stake of 166,790 shares — an estimated $4.49M sold.

Gratry & Company first reported a position in NVO in Q2 2013 and held it in 13 quarters. The position peaked at $9.88M in Q1 2014. 511 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

  • Gratry & Company reported no remaining Novo Nordisk position as of Q3 2016 after selling out during the quarter.
  • Gratry & Company sold 166,790 Novo Nordisk shares in Q3 2016, an estimated $4.49M.
  • Gratry & Company first reported a position in Novo Nordisk in Q2 2013 and held it in 13 quarters.
  • Gratry & Company's Novo Nordisk position peaked at $9.88M in Q1 2014.
  • 511 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Gratry & Company's 13F filing for Q3 2016, filed 4 Nov 2016.